MedPath

Glaceum

Ownership
Private
Employees
-
Market Cap
-
Website

A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients

Phase 2
Not yet recruiting
Conditions
Knee Osteoarthritis (Knee OA)
Interventions
Drug: Placebo
First Posted Date
2025-02-25
Last Posted Date
2025-02-25
Lead Sponsor
Glaceum
Target Recruit Count
60
Registration Number
NCT06845553

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Phase 2
Recruiting
Conditions
Parkinson Disease
Interventions
Drug: Placebo
First Posted Date
2024-03-25
Last Posted Date
2025-02-24
Lead Sponsor
Glaceum
Target Recruit Count
90
Registration Number
NCT06329141
Locations
🇰🇷

Hallym University Medical Center, Anyang, Gyeonggi, Korea, Republic of

🇰🇷

The Catholic University of Korea Uijeongbu St.Marys Hostpial, Uijeongbu, Gyeonggi, Korea, Republic of

🇰🇷

Inje University Busan Paik Hospital, Busan, Korea, Republic of

and more 6 locations

A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects

Phase 1
Recruiting
Conditions
Diabetes Mellitus, Type 2
Interventions
Drug: Placebo
First Posted Date
2022-12-08
Last Posted Date
2024-03-21
Lead Sponsor
Glaceum
Target Recruit Count
40
Registration Number
NCT05642377
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses

Phase 1
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2022-04-04
Last Posted Date
2024-03-20
Lead Sponsor
Glaceum
Target Recruit Count
36
Registration Number
NCT05310032
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

Phase 2
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2022-01-19
Last Posted Date
2024-03-19
Lead Sponsor
Glaceum
Target Recruit Count
81
Registration Number
NCT05197556
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Investigate the Effect of Food on the Pharmacokinetics of HSG4112

Phase 1
Completed
Conditions
Obesity
Interventions
First Posted Date
2021-02-01
Last Posted Date
2021-09-24
Lead Sponsor
Glaceum
Target Recruit Count
12
Registration Number
NCT04733001
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112

Phase 1
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2021-02-01
Last Posted Date
2021-11-01
Lead Sponsor
Glaceum
Target Recruit Count
90
Registration Number
NCT04732988
Locations
🇰🇷

Kyungpook National University Hospital, Daegu, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112

Phase 1
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2021-01-11
Last Posted Date
2022-09-09
Lead Sponsor
Glaceum
Target Recruit Count
40
Registration Number
NCT04703764
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

🇰🇷

Kyungpook National University Hospital, Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath